Figure 3.

(A) Time-dependent ROC curve for the CRSRGP signature risk score in the training set. A risk score of 0.071 was used as the cutoff value to divide patients into the HRG and LRG. Risk score of the CRSRGP signature in the two sets. (B) Distribution of patients with different risk scores in the training set and external validation set. The purple and yellow points represent patients in the HRG and patients in the LRG, respectively. (C) Survival status of patients with different risk scores in the training set and external validation set. The purple and yellow points represent patients who were dead and alive, respectively. (D) Heatmap of the prognostic signature scores in the training set and external validation set. The purple and yellow points represent patients in the HRG and patients in the LRG, respectively. (E) Survival analysis of patients in the training set and external validation set. The survival curve shows that patients in the HRG had a poorer outcome than patients in the LRG. ROC, receiver operating characteristic; CRSRGP, circular RNA regulatory stemness-related gene pair; HRG, high-risk group; LRG, low-risk group.